335 related articles for article (PubMed ID: 30251126)
21. Factors associated with symptom severity in women presenting with fecal incontinence.
Menees SB; Smith TM; Xu X; Chey WD; Saad RJ; Fenner DE
Dis Colon Rectum; 2013 Jan; 56(1):97-102. PubMed ID: 23222286
[TBL] [Abstract][Full Text] [Related]
22. Insights into normal and disordered bowel habits from bowel diaries.
Bharucha AE; Seide BM; Zinsmeister AR; Melton LJ
Am J Gastroenterol; 2008 Mar; 103(3):692-8. PubMed ID: 18021288
[TBL] [Abstract][Full Text] [Related]
23. Fecal incontinence in irritable bowel syndrome: Prevalence and associated factors in Swedish and American patients.
Simrén M; Palsson OS; Heymen S; Bajor A; Törnblom H; Whitehead WE
Neurogastroenterol Motil; 2017 Feb; 29(2):. PubMed ID: 27581702
[TBL] [Abstract][Full Text] [Related]
24. Comparison of Patient Impact and Clinical Characteristics Between Urgency and Passive Fecal Incontinence Phenotypes.
Pahwa AK; Khanijow KD; Harvie HS; Arya LA; Andy UU
Female Pelvic Med Reconstr Surg; 2020 Sep; 26(9):570-574. PubMed ID: 29979355
[TBL] [Abstract][Full Text] [Related]
25. Quality of life is markedly improved in patients with fecal incontinence after sacral nerve stimulation.
Devroede G; Giese C; Wexner SD; Mellgren A; Coller JA; Madoff RD; Hull T; Stromberg K; Iyer S;
Female Pelvic Med Reconstr Surg; 2012; 18(2):103-12. PubMed ID: 22453321
[TBL] [Abstract][Full Text] [Related]
26. A pilot study of transcutaneous sacral nerve stimulation for faecal incontinence.
Thomas GP; Norton C; Nicholls RJ; Vaizey CJ
Colorectal Dis; 2013 Nov; 15(11):1406-9. PubMed ID: 23910042
[TBL] [Abstract][Full Text] [Related]
27. The test-retest reliability of fecal incontinence severity and quality-of-life assessment tools.
Hussain ZI; Lim M; Stojkovic S
Dis Colon Rectum; 2014 May; 57(5):638-44. PubMed ID: 24819105
[TBL] [Abstract][Full Text] [Related]
28. Characteristics Associated With Clinically Important Treatment Responses in Women Undergoing Nonsurgical Therapy for Fecal Incontinence.
Richter HE; Jelovsek JE; Iyer P; Rogers RG; Meyer I; Newman DK; Bradley MS; Harm-Ernandes I; Dyer KY; Wohlrab K; Mazloomdoost D; Gantz MG;
Am J Gastroenterol; 2020 Jan; 115(1):115-127. PubMed ID: 31895722
[TBL] [Abstract][Full Text] [Related]
29. Pathophysiology of fecal incontinence in obese patients: A prospective case-matched study of 201 patients.
Brochard C; Vénara A; Bodère A; Ropert A; Bouguen G; Siproudhis L
Neurogastroenterol Motil; 2017 Aug; 29(8):. PubMed ID: 28229523
[TBL] [Abstract][Full Text] [Related]
30. Faecal incontinence intervention study (FINS): self-management booklet information with or without nurse support to improve continence in people with inflammatory bowel disease: study protocol for a randomized controlled trial.
Norton C; Dibley LB; Hart A; Duncan J; Emmanuel A; Knowles CH; Stevens N; Terry H; Verjee A; Kerry S; Hounsome N
Trials; 2015 Oct; 16():444. PubMed ID: 26445224
[TBL] [Abstract][Full Text] [Related]
31. Does the St. Mark's incontinence score reflect patients' perceptions? A review of 390 patients.
Maeda Y; Parés D; Norton C; Vaizey CJ; Kamm MA
Dis Colon Rectum; 2008 Apr; 51(4):436-42. PubMed ID: 18219532
[TBL] [Abstract][Full Text] [Related]
32. Cholestyramine--a useful adjunct for the treatment of patients with fecal incontinence.
Remes-Troche JM; Ozturk R; Philips C; Stessman M; Rao SS
Int J Colorectal Dis; 2008 Feb; 23(2):189-94. PubMed ID: 17938939
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of methylcellulose and loperamide in managing fecal incontinence.
Sze EH; Hobbs G
Acta Obstet Gynecol Scand; 2009; 88(7):766-71. PubMed ID: 19452328
[TBL] [Abstract][Full Text] [Related]
34. The Effect of Nonoperative Management of Chronic Anal Fissure and Hemorrhoid Disease on Bowel Function Patient-Reported Outcomes.
Wilson MZ; Swarup A; T Wilson LR; Ivatury SJ
Dis Colon Rectum; 2018 Oct; 61(10):1223-1227. PubMed ID: 30192331
[TBL] [Abstract][Full Text] [Related]
35. Biofeedback therapy for symptoms of bowel dysfunction following surgery for colorectal cancer.
Bartlett L; Sloots K; Nowak M; Ho YH
Tech Coloproctol; 2011 Sep; 15(3):319-26. PubMed ID: 21755415
[TBL] [Abstract][Full Text] [Related]
36. A Randomized Pilot Study to Compare the Effectiveness of a Low FODMAP Diet vs Psyllium in Patients With Fecal Incontinence and Loose Stools.
Menees SB; Jackson K; Baker JR; Fenner DE; Eswaran S; Nojkov B; Saad R; Lee AA; Chey WD
Clin Transl Gastroenterol; 2022 Feb; 13(3):e00454. PubMed ID: 35060943
[TBL] [Abstract][Full Text] [Related]
37. Bowel habits and fecal incontinence in patients with obesity undergoing evaluation for weight loss: the importance of stool consistency.
Parés D; Vallverdú H; Monroy G; Amigo P; Romagosa C; Toral M; Hermoso J; Saenz-de-Navarrete G
Dis Colon Rectum; 2012 May; 55(5):599-604. PubMed ID: 22513439
[TBL] [Abstract][Full Text] [Related]
38. Secondary changes in bowel function after successful treatment of voiding symptoms with neuromodulation.
Killinger KA; Kangas JR; Wolfert C; Boura JA; Peters KM
Neurourol Urodyn; 2011 Jan; 30(1):133-7. PubMed ID: 20928914
[TBL] [Abstract][Full Text] [Related]
39. The procon incontinence device: a new nonsurgical approach to preventing episodes of fecal incontinence.
Giamundo P; Welber A; Weiss EG; Vernava AM; Nogueras JJ; Wexner SD
Am J Gastroenterol; 2002 Sep; 97(9):2328-32. PubMed ID: 12358252
[TBL] [Abstract][Full Text] [Related]
40. Validating endpoints for therapeutic trials in fecal incontinence.
Noelting J; Zinsmeister AR; Bharucha AE
Neurogastroenterol Motil; 2016 Aug; 28(8):1148-56. PubMed ID: 26948292
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]